Free Shipping on purchases over €100

3M Nexcare Cold Spray, 150 ml
3M Nexcare Cold Spray, 150 ml

3M Nexcare Cold Spray, 150 ml

The Nexcare Cold Spray manufactured by the pharmaceutical company 3M is a product designed for active people who do sporting or demanding activities with a certain frequency. Its function is to provide an immediate cold effect that helps to reduce pain.

SKU: 249210
-15%
4.50
€5.30

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Nexcare Cold Spray manufactured by the pharmaceutical company 3M is a product for non-professional use, designed mainly for use in homes or sports facilities and when the situation requires it. It is based on a quick application of cold, a sensation that can help relieve pain caused by different injuries or superficial blows.

Its formula is quite simple, as it simply contains the gaseous elements that make its spray application possible and menthol. The latter is the material that will cause the cold effect immediately and without side effects if placed on healthy skin.

The cold effect provided by this product is designed to be fairly long-lasting and does not need to be reapplied for a long time. In addition, when applied to the skin, the intense cold it produces causes the nerve endings in the area to go numb and instead of feeling the pain in full capacity, you will feel a slight sensation of it or it may even result in a cooling effect that completely reduces the discomfort for the duration of its effect.

It should be noted that the product will not heal the injury, it simply makes its main symptom, pain, more bearable. It can be applied over a large area of skin, but it is advisable to use it locally on the specific area of skin.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.